chr1-27945381-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014474.4(SMPDL3B):āc.211A>Gā(p.Ile71Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,613,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014474.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMPDL3B | NM_014474.4 | c.211A>G | p.Ile71Val | missense_variant | 2/8 | ENST00000373894.8 | |
SMPDL3B | NM_001009568.3 | c.211A>G | p.Ile71Val | missense_variant | 2/7 | ||
SMPDL3B | XM_011541259.3 | c.301A>G | p.Ile101Val | missense_variant | 3/9 | ||
SMPDL3B | NM_001304579.2 | c.-479A>G | 5_prime_UTR_variant | 2/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMPDL3B | ENST00000373894.8 | c.211A>G | p.Ile71Val | missense_variant | 2/8 | 1 | NM_014474.4 | P1 | |
ENST00000448015.1 | n.287-6302T>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152106Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251382Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135864
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 727242
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152106Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2022 | The c.211A>G (p.I71V) alteration is located in exon 2 (coding exon 2) of the SMPDL3B gene. This alteration results from a A to G substitution at nucleotide position 211, causing the isoleucine (I) at amino acid position 71 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at